Related Experiment Video
Updated: Jun 2, 2025

09:08
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
1.8K
Genetically predict the association between 91 human blood cell perturbation phenotypes and IBD: A Mendelian
Medicine
|January 14, 2025
Summary
This study explored how human blood cell changes relate to inflammatory bowel disease (IBD) using genetic data. It identified specific blood cell traits linked to IBD, offering insights for diagnosis and treatment.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD), including Crohn disease and ulcerative colitis, presents significant challenges due to its chronic and recurrent nature.
- Existing research lacks comprehensive studies on the relationship between altered human blood cell phenotypes and the pathogenesis of IBD.
- Understanding these connections is crucial for advancing IBD management and treatment strategies.
Purpose of the Study:
- To investigate the causal relationships between genetically determined blood cell perturbation traits and IBD phenotypes.
- To identify specific blood cell phenotypes that may play a causal role in IBD development or be influenced by IBD.
- To provide a foundation for novel therapeutic approaches and improved clinical management of IBD.
Main Methods:
- A systematic two-sample Mendelian randomization (MR) study was performed.
- Utilized summary statistics from genome-wide association studies (GWAS).
- Analyzed 91 genetically determined blood cell perturbation traits against 3 IBD phenotypes.
Main Results:
- Forward MR analysis identified 7 blood cell perturbation phenotypes associated with IBD outcomes.
- Reverse MR analysis revealed 9 blood cell perturbation phenotypes influenced by IBD phenotypes.
- The study established links between specific blood cell traits and IBD.
Conclusions:
- Uncovered significant associations between human blood cell perturbation phenotypes and IBD.
- Findings contribute to a deeper understanding of IBD pathogenesis.
- Offers potential for improved early diagnosis, disease monitoring, immune surveillance, prognosis, and personalized IBD treatment.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Inflammatory Bowel Disease I: Ulcerative Colitis
134
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
134
Pedigree Analysis
83.9K
Overview
83.9K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183

